Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials.

ABSTRACT:

SUBMITTER: Simpson EL 

PROVIDER: S-EPMC10091996 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature